Technology & Software Global On demand · 24-48h

Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Strategic Research Report

Global AI-powered Coronary Artery Calcium (CAC) Analysis Sof…
$3,500 USD
Market Research Reports
Strategic Research Report
Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market
$1.96B2025
12.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Dedicated Calcification Scoring Software, Enhanced CT Plaque Analysis Software

By Application: Clinical Diagnosis Treatment, Health Management, Scientific Research, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Aidoc, Cleerly, Nanox.AI, HeartFlow, Siemens Healthineers, Canon Medical Systems, RADLogics, GE HealthCare, Philips Healthcare, Infervision, Deepwise, RSIP Vision

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 111 pages
Market size 2025
$1.96B
Billion USD
Forecast CAGR
12.4%
2025-2032
Forecast 2032
$4.4B
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global AI-powered Coronary Artery Calcium (CAC) Analysis Software market size is predicted to grow from US$ 1,957 million in 2025 to US$ 4,410 million in 2032; it is expected to grow at a CAGR of 12.4% from 2026 to 2032.

AI-powered coronary artery calcium analysis(CAC) software is a medical image-assisted analysis tool based on artificial intelligence technology. It automatically analyzes cardiac CT scan images to accurately identify, locate, and quantify calcified plaques on the coronary artery walls, and calculates the internationally recognized coronary artery calcium score. This software aims to automate or semi-automate the process of manually delineating calcified plaques and calculating scores, which was previously a time-consuming and manual process for radiologists. This improves diagnostic efficiency, standardizes assessment results, and assists in cardiovascular disease risk stratification. The demand stems directly from the "precision prevention" clinical trend driven by the increasing global burden of cardiovascular disease. Its upstream supply chain relies on high-quality labeled cardiac CT image databases, AI algorithm frameworks, and computing power development support, and requires deep technical integration with CT equipment manufacturers' image protocols and post-processing workstations. Downstream deployment occurs through medical institutions (health check centers, cardiology departments, radiology departments) and medical information systems, ultimately serving as a key tool for early screening and risk stratification of cardiac health, supporting personalized health management and public health prevention systems. In 2025, the average selling price of AI-powered coronary artery calcium analysis software was approximately $40,000 per unit, with a gross profit margin of approximately 55%.

Global key AI-powered Coronary Artery Calcium (CAC) Analysis Software players cover Aidoc, Cleerly, Nanox.AI, HeartFlow, Siemens Healthineers, etc.

This report presents a comprehensive overview of the global AI-powered Coronary Artery Calcium (CAC) Analysis Software market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Dedicated Calcification Scoring Software
  • Enhanced CT Plaque Analysis Software

Segment by Deployment Technology

  • Local Deployment
  • Cloud Deployment

Segment by Application

  • Clinical Diagnosis Treatment
  • Health Management
  • Scientific Research
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global AI-powered Coronary Artery Calcium (CAC) Analysis Software market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Clinical Diagnosis Treatment, Health Management, Scientific Research evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.96B
2025
Forecast
$4.4B
2032
CAGR
12.4%
2025–2032
Regions
5
global
Key companies
AidocCleerlyNanox.AIHeartFlowSiemens HealthineersCanon Medical SystemsRADLogicsGE HealthCare
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Dedicated Calcification Scoring SoftwareEnhanced CT Plaque Analysis Software
By Application
Clinical Diagnosis TreatmentHealth ManagementScientific ResearchOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Dedicated Calcification Scoring Software
  • 3.1.3 Enhanced CT Plaque Analysis Software
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Clinical Diagnosis Treatment
  • 4.1.3 Health Management
  • 4.1.4 Scientific Research
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Aidoc
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cleerly
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nanox.AI
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 HeartFlow
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Siemens Healthineers
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Canon Medical Systems
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 RADLogics
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 GE HealthCare
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Philips Healthcare
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Infervision
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Deepwise
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 RSIP Vision
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global AI-powered Coronary Artery Calcium (CAC) Analysis Software market?
The global AI-powered Coronary Artery Calcium (CAC) Analysis Software market is estimated at US$ 1.96 billion in 2025 (base year) and is projected to reach US$ 4.41 billion by 2032.
What is the forecast CAGR for the AI-powered Coronary Artery Calcium (CAC) Analysis Software market?
The market is expected to grow at a CAGR of 12.4% from 2026 to 2032, expanding from US$ 1.96 billion in 2025 to US$ 4.41 billion in 2032, roughly 2.2 times its base-year value.
What is AI-powered Coronary Artery Calcium (CAC) Analysis Software?
AI-powered coronary artery calcium analysis(CAC) software is a medical image-assisted analysis tool based on artificial intelligence technology. It automatically analyzes cardiac CT scan images to accurately identify, locate, and quantify calcified plaques on the coronary artery walls, and calculates the internationally recognized coronary artery calcium score.
How is the AI-powered Coronary Artery Calcium (CAC) Analysis Software market segmented by type?
By type, the market is segmented into Dedicated Calcification Scoring Software and Enhanced CT Plaque Analysis Software.
What are the key applications of AI-powered Coronary Artery Calcium (CAC) Analysis Software?
Key applications covered include Clinical Diagnosis Treatment, Health Management, Scientific Research and Other.
Which companies are profiled in the AI-powered Coronary Artery Calcium (CAC) Analysis Software market report?
Key players profiled include Aidoc, Cleerly, Nanox.AI, HeartFlow, Siemens Healthineers, Canon Medical Systems, RADLogics and GE HealthCare, among 12 companies covered in total.
What geographies does the AI-powered Coronary Artery Calcium (CAC) Analysis Software market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for AI-powered Coronary Artery Calcium (CAC) Analysis Software?
The demand stems directly from the "precision prevention" clinical trend driven by the increasing global burden of cardiovascular disease.
Who should buy the AI-powered Coronary Artery Calcium (CAC) Analysis Software market report?
The report is intended for manufacturers and solution providers, distributors and end users in Clinical Diagnosis Treatment, Health Management and Scientific Research, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the AI-powered Coronary Artery Calcium (CAC) Analysis Software market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.